Business
Man Driving in Car Seat
Getty Images

The first real quarter of tariff impact took a major bite out of automakers’ bottom lines

Even with some trade deals on the books, new car prices are expected to rise in the coming months.

Max Knoblauch

The first quarter of President Trump’s 25% tariff on the auto industry (and 25% tariff on the auto parts industry) is closed, and it’s been a bumpy road for automakers.

Car manufacturers have reported billions of dollars in tariff costs thus far, and many have given foreboding forecasts for the months ahead.

Toyota’s expecting a $9.5 billion hit in its current fiscal year and said tariffs already cost it more than $3 billion between April and June. Detroit automaker GM — which is still anticipating an up to $5 billion tariff charge this year — reported a $1.1 billion impact on profits.

Analysis of financial reports shows that foreign luxury automaker Porsche appears to have been dealt one of the most significant tariff charges as a percentage of quarterly revenue, though US rivals like Ford have been slapped with larger total levy amounts.

In total, the auto industry has reported at least $8.8 billion in tariff charges from April through June — about the market cap of Planet Fitness.

A few trade deals struck by the Trump administration could shift automakers’ tariff fortunes in the coming quarters: UK automakers’ tariff rate was lowered to 10% in May, while the rates for EU and Japanese automakers were lowered to 15% in July. Still, adjustments have already been priced in for some tariff forecasts, including Toyota’s.

With dealer inventories now largely consisting of vehicles built after May — and popular discounting strategies ended — new vehicle prices are expected to hit the gas in the coming months. According to Cox Automotive, prices could be 8% higher by year-end.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.